A comparison of clinical trial enrollment between adolescent and young adult (aya) oncology patients treated at affiliated adult and pediatric oncology centers

Journal of Pediatric Hematology/Oncology

Volumn 31, Issue 12, 2009, Pages 927-929

  Downs Canner, Stephanie ^a   Shaw, Peter H ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Adolescent; Clinical trials; Oncology; Young adult

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BRAIN TUMOR; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SURVIVAL; CHILDHOOD CANCER; CHILDHOOD LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CLINICAL PROTOCOL; CLINICAL TRIAL; EVENT FREE SURVIVAL; EWING SARCOMA; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MELANOMA; NONHODGKIN LYMPHOMA; ONCOLOGY; OSTEOSARCOMA; OUTCOMES RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SARCOMA; TESTIS CANCER; TREATMENT OUTCOME; CANCER CENTER; CLASSIFICATION; COMPARATIVE STUDY; FEMALE; HOSPITAL; MALE; MORTALITY; NEOPLASM; PATIENT PARTICIPATION; STATISTICS; SURVIVAL;

ADOLESCENT; CANCER CARE FACILITIES; CLINICAL TRIALS AS TOPIC; FEMALE; HOSPITALS, PEDIATRIC; HUMANS; MALE; NEOPLASMS; PATIENT PARTICIPATION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 73949092047     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3181b91180     Document Type: Article

References (11)

1. Bleyer AW, Tejada H, Murphy SB, et al. National cancer clinical trials: children have equal access; adolescents do not. J Adolesc Health. 1997;21:366-373.
2. Bleyer W, Barr R. Highlights and challenges. In: Bleyer A, O'Leary M, Barr R, et al, eds. Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of age, Including SEER Incidence and Survival, 1975 to 2000. Bethesda, MD: National Cancer Institute, NIH Pub. No. 06-5767;2006. Also available at: www.seer.cancer.gov/publications/aya.
3. Fern L, Davies S, Eden T, et al. Rates of inclusion of teenagers and young adults in England into National Cancer Research Network clinical trials: Report from the National Cancer Research Institute (NCRI) Teenage and Young Adult Clinical Studies Development Group. Br J Cancer. 2008;99:1967-1974.
4. McTiernan A. Issues surrounding the participation of adolescents with cancer in clinical trials in the UK. Eur J Cancer Care. 2003;12:233-239.
5. Shaw PH, Ritchey AR. Different rates of clinical trial enrollment between adolescents and young adults aged 15 to 22 years old and children under 15 years old with cancer at a children's hospital. J Pediatr Hematol Oncol. 2007;29:811-814.
6. Yeager ND, Hoshaw-Woodard S, Ruymann FB, et al. Patterns of care among adolescents with malignancy in Ohio. J Pediatr Hematol Oncol. 2006;28:17-22.
7. Paulussen S, Ahrens S, Juergens HF. Cure rates in Ewing tumor patients aged over 15 years are better in pediatric oncology units. Results of GPOH CESS/EICESS studies. Proc Am Soc Clin Oncol. 2003;22:816.
8. Stock W, La M, Sanford B, et al. What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies. Blood. 2008;112:1646-1654.
9. Boissel N, Auclerc MF, L'heritier V, et al. Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 Trials. J Clin Oncol. 2003;21:774-780.
10. de Bont JM, Holt B, Dekker AW, et al. Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric vs adult protocols in the Netherlands. Leukemia. 2004;18:2032-2035.
11. Hallböök H, Gustafsson G, Smedmyr B, et al. Treatment outcome in young adults and children >10 years of age with acute lymphoblastic leukemia in Sweden: a comparison between a pediatric protocol and an adult protocol. Cancer. 2006;107:1551-1561.